EXPRES2ION BIOTECHNOLOGIES ApS
CVR 32770487 · Private limited company (ApS) · Active · Low risk
EXPRES2ION BIOTECHNOLOGIES ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 16 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 24.0m and a net result of DKK -21.9m.
Bankruptcy risk for EXPRES2ION BIOTECHNOLOGIES ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32770487
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (16 years)
- Address
- Agern Alle 1
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 531k
- Employees
- 18 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 55.0% |
| Current ratio | 207% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 6 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -9.2m | DKK -24.0m | DKK -38.9m |
| Net profit | DKK -21.9m | DKK -19.8m | DKK -55.6m |
| Equity | DKK 24.0m | DKK 32.8m | DKK 41.9m |
| Total assets | DKK 43.6m | DKK 58.0m | DKK 50.2m |
| Cash | DKK 32.6m | DKK 43.4m | – |
| Short-term debt | DKK 19.0m | DKK 24.2m | – |
| Avg. employees | 18 | 17 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 1 Jan 2023 – 31 Dec 2023 | 164 | ||
| 1 Jan 2022 – 31 Dec 2022 | 179 | ||
| 1 Jan 2021 – 31 Dec 2021 | 185 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 154 | ||
| 1 Jan 2019 – 31 Dec 2019 | 156 | ||
| 1 Jan 2018 – 31 Dec 2018 | 162 | ||
| 1 Jan 2017 – 31 Dec 2017 | 165 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 148 | ||
| 1 Jan 2014 – 31 Dec 2014 | 142 | ||
| 1 Jan 2013 – 31 Dec 2013 | 153 | ||
| 1 Jan 2012 – 31 Dec 2012 | 149 | ||
| 1 Jan 2011 – 31 Dec 2011 | 157 | ||
| 1 Jan 2010 – 31 Dec 2010 | 157 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Andreas Stakemann | ||
| CEO | Charlotte Dyring | ||
| Board | Martin Roland Jensen | Current | |
| Board | Jakob Ole Knudsen | Current | |
| Board | Karin Garre | Current | |
| Board | Michel Jean Baijot | Current | |
| Board | Charlotte Dyring | ||
| Board | Willem Adriaan De Jongh | ||
| Board | Allan Rosetzsky | ||
| Board | Martin Welschof | ||
| Board | Jesper Roested | ||
| Board | Alexander R Duncan | ||
| Board | Charlotte Dyring | ||
| Board | Gitte Laurette Pedersen-Botero | ||
| Board | Sara Sande | ||
| Owner (100%) | Expres2ion Biotech Holding AB | Current | |
| Owner (20%) | AFFITECH A/S | ||
| Owner (25%) | VÆKSTFONDEN | ||
| Owner (15%) | AR CONSULT ApS | ||
| Owner (25%) | EXPRES2ION HOLDING ApS | ||
| Owner (25%) | AR CONSULT ApS | ||
| Owner (33%) | EXPRES2ION HOLDING ApS | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | Green IV ApS | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Auditor | EY Partnership P/S | ||
| Founder | ApS KBUS 38 nr.3117 | Current |
The CEOs' other companies
Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt
- 01-05-24 ApS Bankrupt 17 Mar 2025
- 061746M A/S Bankrupt 3 Oct 2011
- 1 STEP, COPENHAGEN LOGISTIC & DISTRIBUTION ApS Bankrupt 15 Jan 2009
- 1001 WATT ApS Bankrupt 29 Jan 2002
- 123 AF 04.07.2012 ApS Bankrupt 6 Aug 2012
- 1264 ApS Bankrupt 12 Jun 2012
- 1414 EJENDOMSINVEST 10 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST 12 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST ApS Bankrupt 19 Dec 2014
- 1414 INVEST ApS Bankrupt 22 Dec 2015
- 1WAY2PRINT A/S Bankrupt 24 Jul 2003
- 2 X KJAER DK ApS Bankrupt 18 Dec 2024
- 20220608 ApS Bankrupt 18 Jul 2022
- 23K ApS Bankrupt 17 Jan 2022
- 24237982 A/S Bankrupt 25 Apr 2012
- 2BU EJENDOMME ApS Bankrupt 11 Sep 2013
- 2BU HOLDING ApS Bankrupt 2 Oct 2013
- 2Tal enterprise A/S Bankrupt 28 Apr 2020
- 2V AMAGER SYD ApS Bankrupt 20 Dec 2000
- 3 SIGMA ApS Bankrupt 9 Jun 2005
- 30 08 61 71 ApS Bankrupt 1 Dec 2011
- 31. OKTOBER 2008 ApS Bankrupt 18 Sep 2009
- 32 67 71 93 ApS Bankrupt 16 Nov 2011
- 36087374 ApS Bankrupt 10 Jan 2017
- 365 Service Holding ApS Bankrupt 26 Nov 2020
- 365 Service Partner ApS Bankrupt 26 Nov 2020
- 39701804 ApS Bankrupt 14 Aug 2020
- 39704994 ApS Bankrupt 14 Aug 2020
- 3BH ApS Bankrupt 3 May 2019
- 3XE BYG ApS Bankrupt 11 Aug 2017
Charlotte Dyring – 4 other companies
- EXPRES2ION HOLDING ApS Fusioneret
- EnteroTarget ApS Active
- Marigold Innovation ApS Active
- SKCD Holding ApS Active
Address history (3 moves)
| Agern Alle 1, 2970 Hørsholm | |
| Fremtidsvej 3, 2970 Hørsholm | |
| c/o Charlotte Dyring, Hannelundsvej 10, 2960 Rungsted Kyst | |
| Kronprinsessegade 18, 1306 København K |
Former names
| EXPRES2ION BIOTECHNOLOGIES ApS | – now |
| ApS KBURS 17 NR. 6965 | – |
Employees per year
Other companies at the same address
- CysBio ApS Active
- TANNERMEDICO A/S Active
- TOOsonix A/S Active
- WADeJongh Holding ApS Opløst
- Zaphe ApS Active
- immunAware ApS Active
Similar companies in Rudersdal
- GigaVax ApS Holte
- Migalis ApS Vedbæk
- LIVAG ApS Vedbæk
- CysBio ApS Hørsholm
- Ceremedy ApS Virum
- Cell to Cure ApS Birkerød
- JKastrup.ApS Birkerød
- immunAware ApS Hørsholm
- ASTIM Holding ApS Birkerød
- ASRØ Holding ApS Nærum
- Detalo Instruments Aps Birkerød
- ResoTher Pharma A/S Holte
Questions and answers about EXPRES2ION BIOTECHNOLOGIES ApS
Has EXPRES2ION BIOTECHNOLOGIES ApS gone bankrupt?
No, EXPRES2ION BIOTECHNOLOGIES ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of EXPRES2ION BIOTECHNOLOGIES ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the auditor of EXPRES2ION BIOTECHNOLOGIES ApS?
EXPRES2ION BIOTECHNOLOGIES ApS most recently used EY Godkendt Revisionspartnerselskab.
When was EXPRES2ION BIOTECHNOLOGIES ApS founded?
EXPRES2ION BIOTECHNOLOGIES ApS was founded on 1 January 2010.
What is the equity of EXPRES2ION BIOTECHNOLOGIES ApS?
Equity was DKK 24.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.